Literature DB >> 9647360

Mechanistic studies on effervescent-induced permeability enhancement.

J D Eichman1, J R Robinson.   

Abstract

PURPOSE: To determine the mechanism(s) by which effervescence induces penetration enhancement of a broad range of compounds ranging in size, structure, and other physiocochemical properties across rat and rabbit small intestinal epithelium.
METHODS: Effervescent induced penetration enhancement was investigated in vitro by utilization of a modified Ussing chamber diffusion cell apparatus and in vivo by single-pass intestinal perfusion.
RESULTS: Carbon dioxide (CO2) bubbling directly onto rabbit ileum epithelium induced an increase in drug permeability. Mechanistic studies indicated that effects due to CO2 bubble evolution, such as increased drug dissolution rates, mucus thinning/stripping, and pH buffer effects did not contribute to increases in drug flux. Cellular enzyme (5'-ND and LDH) and total protein release assays did not indicate cell membrane perturbation and/or damage. CO2 bubbling induced a reduction in transepithelial electrical resistance (TEER) indicating epithelial disruption due to a structural change of the paracellular pathway. This was further substantiated by a MW dependence on paracellular marker flux. In addition, tissue recovery was relatively rapid, approximately 20 min.
CONCLUSIONS: CO2 bubbling directly onto the intestinal epithelium induced enhanced drug permeability due to an alteration of the paracellular pathway. This, in addition to fluid flow and membrane hydrophobicity concepts, may account for observed increases in drug flux.

Entities:  

Mesh:

Year:  1998        PMID: 9647360     DOI: 10.1023/a:1011936901638

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  A simplified method of quantitating protein using the biuret and phenol reagents.

Authors:  S T Ohnishi; J K Barr
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

Review 2.  Intestinal drug absorption enhancement: an overview.

Authors:  E J van Hoogdalem; A G de Boer; D D Breimer
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

Review 3.  Enzyme release.

Authors:  E Schmidt; F W Schmidt
Journal:  J Clin Chem Clin Biochem       Date:  1987-09

Review 4.  Mechanisms of cell damage and enzyme release.

Authors:  S R Kristensen
Journal:  Dan Med Bull       Date:  1994-09

Review 5.  Barrier function of epithelia.

Authors:  D W Powell
Journal:  Am J Physiol       Date:  1981-10

6.  Relative effects of different surfactants on intestinal absorption and the release of proteins and phospholipids from the tissue.

Authors:  D A Whitmore; L G Brookes; K P Wheeler
Journal:  J Pharm Pharmacol       Date:  1979-05       Impact factor: 3.765

7.  Buffering the stomach content enhances the absorption of diflunisal in man.

Authors:  B Nuernberg; K Brune
Journal:  Biopharm Drug Dispos       Date:  1989 Jul-Aug       Impact factor: 1.627

8.  Autoradiographic determination of permeation pathway of permeability probes across intestinal and tracheal epithelia.

Authors:  T Y Ma; D Hollander; R Riga; D Bhalla
Journal:  J Lab Clin Med       Date:  1993-11

9.  Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility.

Authors:  E S Swenson; W B Milisen; W Curatolo
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

10.  Mechanisms of polyethylene glycol 400 permeability of perfused rat intestine.

Authors:  P Krugliak; D Hollander; T Y Ma; D Tran; V D Dadufalza; K D Katz; K Le
Journal:  Gastroenterology       Date:  1989-11       Impact factor: 22.682

View more
  9 in total

Review 1.  Substance abuse in cancer pain.

Authors:  Tatiana D Starr; Lauren J Rogak; Steven D Passik
Journal:  Curr Pain Headache Rep       Date:  2010-08

2.  Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.

Authors:  Mona Darwish; Mary Kirby; Philmore Robertson; Edward Hellriegel; John G Jiang
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers.

Authors:  Mona Darwish; Kenneth Tempero; Mary Kirby; Jeffrey Thompson
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 4.  Fentanyl buccal tablet: in breakthrough pain in opioid-tolerant patients with cancer.

Authors:  Stephanie K A Blick; Antona J Wagstaff
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Fentanyl buccal tablet for the treatment of breakthrough pain: pharmacokinetics of buccal mucosa delivery and clinical efficacy.

Authors:  Mona Darwish; Ehab Hamed; John Messina
Journal:  Perspect Medicin Chem       Date:  2010-06-04

Review 6.  Clinical use of opioids for cancer pain.

Authors:  Dermot R Fitzgibbon
Journal:  Curr Pain Headache Rep       Date:  2007-08

7.  A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet.

Authors:  Enno Freye
Journal:  J Pain Res       Date:  2008-12-17       Impact factor: 3.133

8.  Formulation, characterization and physicochemical evaluation of amoxicillin effervescent tablets.

Authors:  Abolfazl Aslani; Tahereh Sharifian
Journal:  Adv Biomed Res       Date:  2014-10-20

Review 9.  Piroxicam-β-cyclodextrin: a GI safer piroxicam.

Authors:  C Scarpignato
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.